Renaissance Technologies (RenTech)'s TDOC Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 8.09 M shares of Teladoc Health, Inc. (TDOC) worth $44.07 M, representing 0.07% of the portfolio. First purchased in 2018-Q4, this long-term strategic position has been held for 26 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in TDOC, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2022, adding 4.02 M shares. Largest reduction occurred in Q3 2022, reducing 1.03 M shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Teladoc Health (TDOC) Holding Value Over Time
Track share changes against reported price movement
Quarterly Teladoc Health (TDOC) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +107,400 | Add 1.35% | 8.09 M | $5.45 |
| Q4 2025 | -198,700 | Reduce 2.43% | 7.98 M | $7.00 |
| Q3 2025 | +855,300 | Add 11.68% | 8.18 M | $7.73 |
| Q2 2025 | +775,300 | Add 11.84% | 7.32 M | $8.71 |
| Q1 2025 | +871,700 | Add 15.36% | 6.55 M | $7.96 |
| Q4 2024 | +763,265 | Add 15.54% | 5.67 M | $9.09 |
| Q3 2024 | -558,507 | Reduce 10.21% | 4.91 M | $9.18 |
| Q2 2024 | -63,719 | Reduce 1.15% | 5.47 M | $9.78 |
| Q1 2024 | +658,319 | Add 13.50% | 5.53 M | $15.10 |
| Q4 2023 | +366,200 | Add 8.12% | 4.88 M | $21.55 |
| Q3 2023 | +101,165 | Add 2.30% | 4.51 M | $18.59 |
| Q2 2023 | +1.04 M | Add 30.82% | 4.41 M | $0.03 |
| Q1 2023 | +902,100 | Add 36.56% | 3.37 M | $0.03 |
| Q4 2022 | -981,519 | Reduce 28.46% | 2.47 M | $0.02 |
| Q3 2022 | -1.03 M | Reduce 22.93% | 3.45 M | $25.35 |
| Q2 2022 | +4.02 M | Add 879.24% | 4.48 M | $33.21 |
| Q1 2022 | -866,988 | Reduce 65.48% | 457,019 | $72.13 |
| Q4 2021 | +1.32 M | New Buy | 1.32 M | $91.82 |
| Q1 2021 | -55,982 | Sold Out | 0 | $0.00 |
| Q4 2020 | -611,818 | Reduce 91.62% | 55,982 | $199.96 |
| Q3 2020 | +503,600 | Add 306.70% | 667,800 | $219.24 |
| Q2 2020 | +115,320 | Add 235.92% | 164,200 | $190.84 |
| Q1 2020 | -493,820 | Reduce 90.99% | 48,880 | $155.01 |
| Q4 2019 | +542,700 | New Buy | 542,700 | $83.72 |
| Q1 2019 | -77,100 | Sold Out | 0 | $0.00 |
| Q4 2018 | +77,100 | New Buy | 77,100 | $49.57 |
Renaissance Technologies (RenTech)'s Teladoc Health Investment FAQs
Renaissance Technologies (RenTech) first purchased Teladoc Health, Inc. (TDOC) in Q4 2018, acquiring 77,100 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Teladoc Health, Inc. (TDOC) for 26 quarters since Q4 2018.
Renaissance Technologies (RenTech)'s largest addition to Teladoc Health, Inc. (TDOC) was in Q2 2022, adding 4,475,319 shares worth $148.62 M.
According to the latest 13F filing for Q1 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 8,085,542 shares of Teladoc Health, Inc. (TDOC), valued at approximately $44.07 M.
As of the Q1 2026 filing, Teladoc Health, Inc. (TDOC) represents approximately 0.07% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Teladoc Health, Inc. (TDOC) was 8,176,842 shares, as reported at the end of Q3 2025.